Popular
Ready, Set, Act! Opportunities to Address Persistent Unmet Needs in Patients With HFrEF: A Case-Based Discussion
CME/CEReady, Set, Act! Opportunities to Address Persistent Unmet Needs in Patients With HFrEF: A Case-Based Discussion
Carolyn Lam, MD, PhD
Stephen J. Greene, MD
Hypopigmentation in Atopic Dermatitis Patients with Skin of Color
Dermatology Hub: Neuroimmune NetworkHypopigmentation in Atopic Dermatitis Patients with Skin of Color
Cheri Frey, MD
When Skin and Itch Do Not Match in Atopic Dermatitis
Dermatology Hub: Neuroimmune NetworkWhen Skin and Itch Do Not Match in Atopic Dermatitis
Elizabeth Swanson, MD, FAAD
- CME/CE In-Person & Virtual Event
Spotlight on B7-H3 ES-SCLC: Applying ADC Evidence in Real-World Practice
December 5, 2026
Scottsdale, Arizona Helping Patients Stay on Track With Collaborative LDL-C Care
Medical Industry FeatureHelping Patients Stay on Track With Collaborative LDL-C Care
Barry D. Bertolet MD, FACC
Todd Sandroni PharmD
Brian P. McDonough, MD, FAAFP
Michael Moor, MD, PhD
Programs
Continuous Glucose and Ketone Monitoring: Making Smarter Decisions in Diabetes
CME/CEContinuous Glucose and Ketone Monitoring: Making Smarter Decisions in Diabetes
Stephen Brunton, MD, FAAFP, CDCES
James R. Gavin III, MD, PhD
Davida F. Kruger, MSN, APN-BC, BC-ADM
Eden Miller, DO, D-ACD, D-ABOM
ACACIA-HCM: What Do the Phase 3 Results Show?
CardiologyACACIA-HCM: What Do the Phase 3 Results Show?
Ahmad Masri, MD, MS
Navigating Chronic Anticoagulation Reversal in Cardiothoracic Surgery
Heart MattersNavigating Chronic Anticoagulation Reversal in Cardiothoracic Surgery
Brian P. McDonough, MD, FAAFP
Ahmet Kilic, MD FACS
Recurrence as the Rule: BD Symptoms Persist and Cycle
MinuteCE®Recurrence as the Rule: BD Symptoms Persist and Cycle
Jose M. Rubio, MD, PhD
Sunny X. Tang, MD
Navigating the Limitations of Current BD Therapies
MinuteCE®Navigating the Limitations of Current BD Therapies
Jose M. Rubio, MD, PhD
Sunny X. Tang, MD
Hypoparathyroidism – The Critical Role of Genetics in Your Differential Diagnosis
CME/CEHypoparathyroidism – The Critical Role of Genetics in Your Differential Diagnosis
Dolores Shoback, MD
Michael T. Collins, MD
Clinical Practice
APOC3 Inhibition in FCS and Severe Hypertriglyceridemia
CardiologyAPOC3 Inhibition in FCS and Severe Hypertriglyceridemia
Erik Stroes
Emerging Perspectives: The Potential Role of Xanomeline Trospium Across the Bipolar Spectrum
MinuteCE®Emerging Perspectives: The Potential Role of Xanomeline Trospium Across the Bipolar Spectrum
Jose M. Rubio, MD, PhD
Sunny X. Tang, MD
Redefining Endocrine Therapy: The Evidence Behind Oral SERDs and PROTAC ER Degraders
MinuteCE®Redefining Endocrine Therapy: The Evidence Behind Oral SERDs and PROTAC ER Degraders
Komal Jhaveri, MD, FACP
Oral GLP-1 RA Therapy in Type 2 Diabetes and High Cardiovascular Risk
CME/CEOral GLP-1 RA Therapy in Type 2 Diabetes and High Cardiovascular Risk
Brian P. McDonough, MD, FAAFP
Silvio Inzucchi, MD
Jay H. Shubrook, DO, FACOFP, FAAFP
The Sequencing Puzzle: Integrating Oral SERDs and PROTACs into the mBC Treatment Landscape
MinuteCE®The Sequencing Puzzle: Integrating Oral SERDs and PROTACs into the mBC Treatment Landscape
Komal Jhaveri, MD, FACP
Virginia Kaklamani, MD, DSc
Clinical Evidence for Anti-CD38–Based Frontline Regimens in Transplant-Eligible Patients With Multiple Myeloma
MinuteCE®Clinical Evidence for Anti-CD38–Based Frontline Regimens in Transplant-Eligible Patients With Multiple Myeloma
Natalie S. Callander, MD
Doctors Lounge
Brian P. McDonough, MD, FAAFP
Raja-Elie E. Abdulnour, MD
Jean-Claude Saghbini
Engaging Patients and Caregivers About Digital Therapeutics
Medical Industry FeatureEngaging Patients and Caregivers About Digital Therapeutics
Charles Turck, PharmD, BCPS, BCCCP
Maggie Emerson, DNP, APRN, PMHNP-BC
Bruno Batinica, MD
Optimizing Medical Affairs Approaches with CME Best Practices
MAPSChatsOptimizing Medical Affairs Approaches with CME Best Practices
Matt Birnholz, MD
Karen Roy, MSc
“We have the opportunity to understand what happens when someone leaves the clinic,” says Dr. Rajiv Kumar of Apple and Stanford Medicine
The Convergence“We have the opportunity to understand what happens when someone leaves the clinic,” says Dr. Rajiv Kumar of Apple and Stanford Medicine
Brian P. McDonough, MD, FAAFP
Rajiv Kumar, MD
"We have tools that can think alongside us and free us from a lot of burdens," says Dr. Raja-Elie Abdulnour from NEJM Clinician
The Convergence"We have tools that can think alongside us and free us from a lot of burdens," says Dr. Raja-Elie Abdulnour from NEJM Clinician
Brian P. McDonough, MD, FAAFP
Raja-Elie E. Abdulnour, MD
CME
The Next Frontier: Addressing Persistent Cognitive Impairment in Bipolar Disorder
MinuteCE®The Next Frontier: Addressing Persistent Cognitive Impairment in Bipolar Disorder
Jose M. Rubio, MD, PhD
Sunny X. Tang, MD
- MinuteCE®
Exploring the Potential Role of Emerging Muscarinic Therapies in the Treatment of Bipolar Disorder
Jose M. Rubio, MD, PhD
Sunny X. Tang, MD
Navigating Treatment Selection After First-line CDK4/6 Inhibitor Progression
MinuteCE®Navigating Treatment Selection After First-line CDK4/6 Inhibitor Progression
Komal Jhaveri, MD, FACP
Virginia Kaklamani, MD, DSc
Case Consult: Implementing Anti-CD38–Based Frontline Regimens in Transplant-Eligible Patients
MinuteCE®Case Consult: Implementing Anti-CD38–Based Frontline Regimens in Transplant-Eligible Patients
Saad Z. Usmani, MD, MBA
Natalie S. Callander, MD
PSVT Management: Suboptimal Care Is Too Frequent
MinuteCE®PSVT Management: Suboptimal Care Is Too Frequent
Brian P. Rose, PA-C, MPH, AACC
Industry Feature
Centanafadine for Management of Executive Dysfunction and Emotional Dysregulation in Adults with ADHD
Innovations In MedicineCentanafadine for Management of Executive Dysfunction and Emotional Dysregulation in Adults with ADHD
Charles Turck, PharmD, BCPS, BCCCP
Joel L. Young, MD
Taking Action in Friedreich Ataxia From Diagnosis to Treatment
Medical Industry FeatureTaking Action in Friedreich Ataxia From Diagnosis to Treatment
Jennifer Caudle, DO, FACOFP
David Lynch, MD
Laura Bleekrode, MD
Unraveling PMR Pathophysiology: The Central Role of IL-6
Medical Industry FeatureUnraveling PMR Pathophysiology: The Central Role of IL-6
Charles Turck, PharmD, BCPS, BCCCP
Adam Brown, MD
Megan Sullivan, MD
Navigating ASCVD and Pancreatitis Risk in Severe Hypertriglyceridemia
Innovations In MedicineNavigating ASCVD and Pancreatitis Risk in Severe Hypertriglyceridemia
Charles Turck, PharmD, BCPS, BCCCP
Andrew Freeman, MD, FACC, FACP
Putting Into Practice: ctDNA Monitoring of ESR1 Mutations During 1L HR+/HER2− Advanced Breast Cancer
Innovations In MedicinePutting Into Practice: ctDNA Monitoring of ESR1 Mutations During 1L HR+/HER2− Advanced Breast Cancer
The Patient You Might Be Missing: Severe Hypertriglyceridemia in Clinical Practice
Medical Industry FeatureThe Patient You Might Be Missing: Severe Hypertriglyceridemia in Clinical Practice
Charles Turck, PharmD, BCPS, BCCCP
Erin D. Michos, MD, MHS, FACC, FAHA, FASE, FASPC